Lakshmayya Nunna Sai Venkata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lakshmayya Nunna Sai Venkata has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Awdhesh Kumar Mishra
Department of Biotechnology, Yeungnam University, Gyeongsan, Republic of Korea
3 shared publications - Bishwambhar Mishra
Department of Biotechnology, Chaitanya Bharathi Institute of Technology (CBIT), Gandipet, Hyderabad, India
3 shared publications - Kwang-Hyun Baek
Department of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea
3 shared publications - Yugal Kishore Mohanta
Nano-biotechnology and Translational Knowledge Laboratory, Department of Applied Biology, University of Science and Technology Meghalaya
3 shared publications - Sarvesh Rustagi
Uttaranchal University
2 shared publications - Anjali Tomar
School of Agricultural Sciences, K.R. Mangalam University, Gurugram 122103, Haryana, India
1 shared publication
Latest Publications
- Open Access
The Gut Gambit: A Review of How Microbial Imbalance Fuels Metabolic Mayhem
Background/Objectives: An imbalance in gut microbiota, known as gut dysbiosis, results in reactive oxygen species overproduction, which can cause inflammatory conditions, damage DNA, trigger immunity, and induce epigenetic modifications of crucial genes that regulate metabolic pathways. Such a condition can also weaken the resilience of the protective gut wall and elevate colon permeability, allowing toxins from the gut to reach the liver and bloodstream, contributing to oxidative damage, autoimmune diseases, and epigenetic changes linked to metabolic disorders. Methods: The Scopus database was exclusively searched for the literature. Relevant articles were identified using predefined keywords, including gut dysbiosis, microbiota, microbiome, oxidative stress, metabolic disorders, inflammation, and epigenetics or combinations. Gut microbiota- and diet-induced metabolic disorders, particularly obesity, insulin resistance, dyslipidemia, and hypertension, may be inherited through epigenetic pathways. Results: The evidence analyzed suggests that the gut microbiota serves as a diverse metabolic and immunological organ. Its disruption affects the production of short-chain fatty acids, bile acid metabolism, immune signaling, and the redox balance, which contributes to the development of obesity, insulin resistance, and metabolic syndrome. Conclusions: This review highlights key epigenetic mechanisms underlying metabolic disorders and oxidative stress in the context of gut dysbiosis. Furthermore, therapeutic strategies targeting the gut microbiota, such as dietary interventions, prebiotics, probiotics, postbiotics, and fecal microbiota transplantation, hold promise for mitigating oxidative stress and inflammation associated with metabolic syndrome.
Open AccessThe Gut Gambit: A Review of How Microbial Imbalance Fuels Metabolic Mayhem
Background/Objectives: An imbalance in gut microbiota, known as gut dysbiosis, results in reactive oxygen species overproduction, which can cause inflammatory conditions, damage DNA, trigger immunity, and induce epigenetic modifications of crucial genes that regulate metabolic pathways. Such a condition can also weaken the resilience of the protective gut wall and elevate colon permeability, allowing toxins from the gut to reach the liver and bloodstream, contributing to oxidative damage, autoimmune diseases, and epigenetic changes linked to metabolic disorders. Methods: The Scopus database was exclusively searched for the literature. Relevant articles were identified using predefined keywords, including gut dysbiosis, microbiota, microbiome, oxidative stress, metabolic disorders, inflammation, and epigenetics or combinations. Gut microbiota- and diet-induced metabolic disorders, particularly obesity, insulin resistance, dyslipidemia, and hypertension, may be inherited through epigenetic pathways. Results: The evidence analyzed suggests that the gut microbiota serves as a diverse metabolic and immunological organ. Its disruption affects the production of short-chain fatty acids, bile acid metabolism, immune signaling, and the redox balance, which contributes to the development of obesity, insulin resistance, and metabolic syndrome. Conclusions: This review highlights key epigenetic mechanisms underlying metabolic disorders and oxidative stress in the context of gut dysbiosis. Furthermore, therapeutic strategies targeting the gut microbiota, such as dietary interventions, prebiotics, probiotics, postbiotics, and fecal microbiota transplantation, hold promise for mitigating oxidative stress and inflammation associated with metabolic syndrome.
- 26 April 2025
- Published by Springer Nature in Waste and Biomass Valorization
- Vol. 16 (7) , 3331-3355
Agro-Waste-Derived Bioplastics: Sustainable Innovations for a Circular Economy
- 26 April 2025
- Published by Springer Nature in Waste and Biomass Valorization
- Vol. 16 (7) , 3331-3355
Agro-Waste-Derived Bioplastics: Sustainable Innovations for a Circular Economy
- Open Access
- 23 December 2021
- Published by MDPI AG in Metabolites
- Vol. 12 (1) , 12
Antifungal Metabolites as Food Bio-Preservative: Innovation, Outlook, and Challenges
Perishable food spoilage caused by fungi is a major cause of discomfort for food producers. Food sensory abnormalities range from aesthetic degeneration to significant aroma, color, or consistency alterations due to this spoilage. Bio-preservation is the use of natural or controlled bacteria or antimicrobials to enhance the quality and safety of food. It has the ability to harmonize and rationalize the required safety requirements with conventional preservation methods and food production safety and quality demands. Even though synthetic preservatives could fix such issues, there is indeed a significant social need for “clean label” foods. As a result, consumers are now seeking foods that are healthier, less processed, and safer. The implementation of antifungal compounds has gotten a lot of attention in recent decades. As a result, the identification and characterization of such antifungal agents has made promising advances. The present state of information on antifungal molecules, their modes of activity, connections with specific target fungi varieties, and uses in food production systems are summarized in this review.
- 23 December 2021
- Published by MDPI AG in Metabolites
- Vol. 12 (1) , 12
Open AccessAntifungal Metabolites as Food Bio-Preservative: Innovation, Outlook, and Challenges
Perishable food spoilage caused by fungi is a major cause of discomfort for food producers. Food sensory abnormalities range from aesthetic degeneration to significant aroma, color, or consistency alterations due to this spoilage. Bio-preservation is the use of natural or controlled bacteria or antimicrobials to enhance the quality and safety of food. It has the ability to harmonize and rationalize the required safety requirements with conventional preservation methods and food production safety and quality demands. Even though synthetic preservatives could fix such issues, there is indeed a significant social need for “clean label” foods. As a result, consumers are now seeking foods that are healthier, less processed, and safer. The implementation of antifungal compounds has gotten a lot of attention in recent decades. As a result, the identification and characterization of such antifungal agents has made promising advances. The present state of information on antifungal molecules, their modes of activity, connections with specific target fungi varieties, and uses in food production systems are summarized in this review.